West Branch Capital LLC Amgen Inc Transaction History

West Branch Capital LLC

$234 Million
Q1 2024

A detailed history of West Branch Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, West Branch Capital LLC holds 1,490 shares of AMGN stock, worth $464,075. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,490

Previous 1,695 12.09%

Holding current value

$464,075

Previous $488,000 13.32%

% of portfolio

0.18%

Previous 0.24%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $55,118 - $66,534	-205 Reduced 12.09%	1,490 $423,000
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $110,973 - $125,191	434 Added 34.42%	1,695 $488,000
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $218 - $271	1 Added 0.08%	1,261 $338,000
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $2,356 - $2,787	11 Added 0.88%	1,260 $279,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $225 - $275	1 Added 0.08%	1,249 $301,000

Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.08%	1,248 $0
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $90,008 - $101,513	401 Added 47.4%	1,247 $281,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 3.42%	846 $206,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $9,209 - $10,187	-42 Reduced 4.58%	876 $212,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $3,182 - $3,641	-16 Reduced 1.71%	918 $207,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $28,019 - $32,828	-132 Reduced 12.38%	934 $199,000
Q2 2021 Aug 17, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.09%	1,066 $259,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $4,216 - $4,913	-19 Reduced 1.75%	1,065 $265,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $109,055 - $129,865	-504 Reduced 31.74%	1,084 $249,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $303,167 - $337,147	-1,292 Reduced 44.86%	1,588 $404,000
Q2 2020 Jul 08, 2020	SELL	$197.81 - $242.74 $494,129 - $606,364	-2,498 Reduced 46.45%	2,880 $679,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $59,774 - $79,277	-328 Reduced 5.75%	5,378 $1.09 Million
Q4 2019 Jan 07, 2020	SELL	$189.21 - $243.2 $3,973 - $5,107	-21 Reduced 0.37%	5,706 $1.38 Million
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $127,970 - $153,335	735 Added 14.72%	5,727 $1.11 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $833 - $977	-5 Reduced 0.1%	4,992 $920,000
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $26,226 - $29,562	-145 Reduced 2.82%	4,997 $949,000
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $10,525 - $12,286	-59 Reduced 1.13%	5,142 $1 Million
Q3 2018 Oct 16, 2018	SELL	$185.29 - $208.89 $12,599 - $14,204	-68 Reduced 1.29%	5,201 $1.08 Million
Q2 2018 Aug 02, 2018	BUY	$166.05 - $186.51 $108,098 - $121,418	651 Added 14.1%	5,269 $973,000
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $782,427 - $914,364	4,618 New	4,618 $787,000

Others Institutions Holding AMGN

# of Institutions

2,934

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Account

West Branch Capital LLC Amgen Inc Transaction History